Artemis Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.48M Sell
108,284
-2,576
-2% -$176K 0.08% 158
2026
Q1
$7.16M Sell
110,860
-3,736
-3% -$263K 0.08% 150
2025
Q4
$7.71M Buy
114,596
+14,638
+15% +$985K 0.09% 141
2025
Q3
$7.33M Sell
99,958
-25,694
-20% -$1.71M 0.09% 144
2025
Q2
$6.54M Hold
125,652
0.08% 163
2025
Q1
$8.02M Buy
+125,652
New +$7.3M 0.12% 138

Other funds holding HALO

Artemis Investment Management's HALO Position: Q2 2026 in Review

Artemis Investment Management reduced its Halozyme (HALO) stake by 2.3% in Q2 2026, selling an estimated $176K and leaving 108,284 shares worth $8.48M. The position accounts for 0.08% of the portfolio, ranked #158.

Artemis Investment Management first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Artemis Investment Management held 108,284 shares of Halozyme worth $8.48M as of Q2 2026.
  • Artemis Investment Management sold 2,576 Halozyme shares in Q2 2026, an estimated $176K.
  • Halozyme made up 0.08% of Artemis Investment Management's portfolio in Q2 2026, its #158 holding.
  • Artemis Investment Management first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.